Please login to the form below

COPD

This page shows the latest COPD news and features for those working in and with pharma, biotech and healthcare.

UK biotech Synairgen treats first patient in phase 3 COVID-19 trial

Prior to the COVID-19 pandemic, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in

Latest news

Synairgen’s SNG001 advances into phase 3 COVID-19 trial

UK biotech had initially been testing drug for COPD and asthma. ... response. Initially, Synairgen had been evaluating the drug as a treatment for COPD and asthma, although its focus has now shifted to investigating SNG001’s potential in COVID-19
Positive COPD data for Synairgen's SNG001 supports COVID-19 programme

Interim analysis from the phase 2 trial in COPD patients with confirmed respiratory viral infection found that treatment with SNG001 improved lung antiviral responses compared to placebo. ... He added that, despite the encouraging data in COPD, this
Policy and public health: ML and AI in healthcare

If you smoke ten packs of cigarettes per day, you will likely suffer from emphysema or COPD or some other respiratory illness.
GSK seeks EU approval for Trelegy in adult asthma patients

Triple respiratory drug Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is already approved in the EU and US for use in chronic obstructive pulmonary disease (COPD) patients, although GSK is now keen ... The expansion into asthma is also
GSK licenses its tuberculosis vaccine to Gates MRI

It’s in-house R&D in this area is focused on vaccines against respiratory syncytial virus (RSV), bacteria that contribute to chronic obstructive pulmonary disease (COPD) and a new meningitis

More from news
Approximately 71 fully matching, plus 226 partially matching documents found.

Latest Intelligence

On our best behaviour

The main disease areas of focus have understandably been chronic diseases, including obesity, diabetes, cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).
Exploring the potential of eosinophils

Interestingly, Howarth explained that a proportion of patients with COPD also have eosinophilic inflammation.
Could formulary intelligence be your brand differentiator?

Spiolto – a LAMA/LABA combination for COPD and heir to Boehringer’s blockbuster Spiriva.
AI: the smart money is on the smart thinking

The software helps differentiate patients from those suffering with similar symptoms that are actually a result of asthma and chronic obstructive pulmonary disease (COPD), and therefore diagnose CTEPH more reliably and
The impact of COVID-19 on clinical trials

Patient populations – trials with vulnerable populations (eg, the elderly, the immunocompromised, patients with pulmonary conditions such as COPD).

More from intelligence
Approximately 0 fully matching, plus 46 partially matching documents found.

Latest appointments

Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

in development for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and cystic fibrosis. ... for the maintenance treatment of COPD.”.
Vikas Sinha joins Verona as non-executive director

A potential first-in-class treatment for chronic obstructive pulmonary disease (COPD), Verona Pharma's RPL554 is being tested as a nebulised maintenance treatment for patients with moderate to severe disease.
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia

Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Frontera wins at IPA Best of Health 2016

The Silver was awarded for ‘Breathing is everything’, an interactive video created for healthcare professionals that offers a live-action experience of what COPD patients go through on a daily basis.
Clinical trial recruitment on podcasts: is it a good idea?

There’s a whole array of podcasts about different conditions out there, from COPD to dementia.
Insights from patients during the COVID-19 pandemic

We carried out a survey among patients who have any one of these conditions: chronic obstructive pulmonary disorder (COPD), ulcerative colitis (UC), Crohn’s disease (CD) and idiopathic pulmonary fibrosis (IPF). ... Very few respondents were currently
Covid-19 drives change in long-term conditions management

A key resource in this field is myCOPD - a specialist self-care app designed and built by COPD experts, and externally peer-reviewed by leading NHS consultants.
Addressing Climate Impact: The Healthcare Paradox

Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.

More from PMHub
Approximately 0 fully matching, plus 19 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Medical Editor: Competitive

Healthcare Lead Copywriter: Competitive

Healthcare Senior Account Manager: Competitive

Account Director – Creative Healthcare Communications: Competative

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

PMHub

Add my company

KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....